This inventor holds 2 USPTO granted patents and 1 published patent application and 1 EPO patent. Top assignees: Xiamen University, Xiamen Zeesan Biotech Co., Ltd.. Active years: 2021-2023.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2021-2023
Title: Innovations of Dongmei Chen
Introduction
Dongmei Chen is a notable inventor based in Xiamen, China. He has made significant contributions to the field of nucleic acid detection, holding 2 patents that showcase his innovative methods. His work is particularly relevant in the context of multiplex detection, which allows for the simultaneous analysis of multiple target nucleic acid sequences.
Latest Patents
One of Dongmei Chen's latest patents is a method for detecting target nucleic acid sequences. This application relates to multiplex detection of nucleic acid molecules. The method enables the simultaneous detection of multiple target nucleic acid sequences in a sample. Additionally, the application provides a probe set and a kit that includes one or more of these probe sets, which can be utilized to implement the method effectively.
Career Highlights
Dongmei Chen has worked with esteemed institutions such as Xiamen University and Xiamen Zeesan Biotech Co., Ltd. His experience in these organizations has contributed to his expertise in the field of biotechnology and molecular diagnostics.
Collaborations
Some of his notable coworkers include Qingge Li and Qiuying Huang, who have collaborated with him on various projects.
Conclusion
Dongmei Chen's innovative approaches to nucleic acid detection highlight his significant contributions to biotechnology. His patents reflect a commitment to advancing methods that enhance the accuracy and efficiency of molecular diagnostics.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile